Skip to main content
. 2017 Jan 20;143(5):873–882. doi: 10.1007/s00432-016-2331-0

Table 3.

Treatment response

Chemotherapy (n = 41), n (%) Decitabine priming (n = 40), n (%) p value
OR 21 (51.2%) 30 (75.0%) 0.027
CR 12 (29.3%) 22 (55.0%) 0.019
PR 0 0
mCR/HI 9 (22.0%) 8 (20.0%) 0.829
SD 8 (19.5%) 3 (7.5%) 0.115
Failure 12 (29.3%) 7 (17.5%) 0.211

CR complete remission, PR partial remission, mCR/HI marrow complete remission/hematologic improvement, SD stable disease, failure treatment failure, OR overall response (CR + PR + mCR/HI)